(Total Views: 504)
Posted On: 11/08/2019 12:40:42 PM
Post# of 194

$ABBV News Article - AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia https://marketwirenews.com/news-releases/abbv...74247.html


My Twitter: WhyteStocks